KIT and FGFR3 have a direct interaction in GIST cells, and BGJ398, a selective FGFR1-4 inhibitor, can re-sensitize GIST to IM in in vitro and in vivo experiments [170]. Here, FGFR3 is linked to gastrointestinal stromal tumor.